Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 71 results for "julie masow"

Mnangagwa sucked into church wrangle

HARARE - The family of Aaron Mhukuta-Gomo, the leader of the Johane Masowe Vadzidzi VaJesu, has appealed for the intervention of police commissioner-general Augustine Chihuri, in a vicious leadership wrangle with fellow church members that is ... Daily News Zimbabwe, 1 month ago
[x]  

FDA approves Novartis drug Odomzo® (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer

/PRNewswire/ --Novartis today announced the US Food and Drug Administration (FDA) has approved Odomzo ® (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has ...
 Town Hall1 month ago 7/24/15 - FDA approves Novartis drug Odomzo® (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer  Pharmacy Choice1 month ago FDA approves Novartis drug Odomzo?? (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer  Review Seeker1 month ago
[x]  

Witchdoctor rapes teenage client

Tendai Rupapa Senior Court Reporter A 71-year-old self-styled witchdoctor allegedly drugged a 17-year-old girl who had visited his house for consultations before raping her, the court heard on Wednesday. The victim, who was experiencing marital ...
 Zimbabwe Daily1 month ago
PR Newswire

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto (sacubitril/valsartan)

/PRNewswire/ --Novartis announced today that the US Food and Drug Administration (FDA) has approved Entresto (sacubitril/valsartan) tablets, previously known as LCZ696, to reduce the risk of cardiovascular death and hospitalization for heart ...
 RCL Advisors1 month ago
[x]  
MSN News US

FDA Approves Blockbuster Heart Drug

Novartis Pharmaceuticals new heart failure drug called Entresto, which is , earned FDA approval on Tuesday six weeks before the agency's priority review action date when the decision was expected. The drug has been hyped as a multi-blockbuster by ...
 MSN News US1 month ago Novartis Earns FDA Approval For New $5B 'Blockbuster' Drug For Heart Failure Called Entresto And Reveals $12.50-A-Day Price  International Business Times1 month ago

Feds want Novartis to cough up $3.4B in damages, fines in kickback case

'; if(pArray.length >= 4) { i=2; } else if(pArray.length >= 3) { i=2; inline = ''; } else if(pArray.length >= 2) { i=1; inline = ''; } else if(pArray.length === 1) { i=0; inline = ''; } $('#librarydrawer_story_container script').each(function() { ...
 FiercePharma2 months ago

US seeks up to $3.35 billion from Novartis over alleged kickbacks to boost Exjade, Myfortic sales

The US Department of Justice filed a lawsuit in federal court that seeks to hold Novartis liable for as much as $3.35 billion in damages and civil fines over alleged kickback schemes that led to improper reimbursements for its iron chelation therapy ...
 FirstWord Pharma2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less